Ventyx Biosciences, Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ventyx Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q3 2024.
  • Ventyx Biosciences, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 9.87 %, a 40.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 9.87 +2.83 +40.2% Sep 30, 2024
Q2 2024 11.2 +4.77 +73.8% Jun 30, 2024
Q1 2024 10.1 +3.41 +50.7% Mar 31, 2024
Q4 2023 8.99 +1.55 +20.8% Dec 31, 2023
Q3 2023 7.04 -0.44 -5.89% Sep 30, 2023
Q2 2023 6.47 -2.46 -27.6% Jun 30, 2023
Q1 2023 6.73 Mar 31, 2023
Q4 2022 7.44 Dec 31, 2022
Q3 2022 7.47 Sep 30, 2022
Q2 2022 8.93 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.